<DOC>
	<DOCNO>NCT00572091</DOCNO>
	<brief_summary>Improvement heart failure moderate severe mitral regurgitation use percutaneously deliver implanted device</brief_summary>
	<brief_title>Aachen Safety Efficacy Percutaneous Transvenous Mitral Annuloplasty Device Reduce Mitral Regurgitation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Symptomatic heart failure functional MR 2+ 4+ LVEF 20 % 50 % MR organic origin significant comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Mitral Regurgitation</keyword>
</DOC>